• Blood supply from upper vaginal and uterine arteries
  • Lymph drains to the obturator and internal and external iliac nodes and then to the para-aortic nodes
  • Cervical carcinoma commonly spreads via the lymph

Benign conditions of the cervix

Cervical ectopy

  • Also called erosion
  • When the columnar epithelium of the endocervix is visible as a red area around the os
  • Normal in younger women especially those that are pregnant or those that are on the contraceptive pill

Cervical ectropion

  • Results from minor lacerations during childbirth
  • Appears as more irregular redness
  • Can cause vaginal discharge or post coital bleeding
  • Treated by cyrotherapy
  • Exposed columnar epithelium is more susceptible to infection

Acute cervicitis

  • Rare
  • Often results from STD
  • May result in vaginal discharge
  • Cervix appears red, congested and swollen

Chronic cervicitis

  • Chronic inflammation/infection
  • Often involves an ectopy or ectropion
  • Presentation is with pelvic pain, discharge or superficial dyspareunia

Cervical polyps

  • Benign tumours of the endocervical epithelium
  • Most common over the age of 40
  • May cause IMB or PCB

Nabothian follicles

  • Occurs where squamous epithelium has formed by metaplasia over endocervical cells
  • Columnar cell excretions are trapped, forming cysts which appear as white swellings on the ectocervix

Premalignant conditions of the cervix CIN

  • CIN is the presence of atypical, mitotic, dykaryotic cells with large nuclei within the squamous epithelium
  • CIN is a histological diagnosis, graded I-III
    • CIN I  mild dysplasia, atypical cells found only in the lower 1/3 of epithelium
    • CIN II  moderate dysplasia, atypical cells found in lower 2/3 of epithelium
    • CIN III  severe dysplasia, atypical cells in the full thickness of the epithelium. Also called carcinoma in situ
  • If untreated 1/3 of the women with CIN II/III will develop cervical cancer over 10 years
  • CIN I can progress to CIN II/III but often spontaneously regresses
  • CIN is becoming more common, it is more prevalent in women aged 35-45 and in lower socio-economic classes

Investigation/Treatment

  • Colposcopy - grades of CIN have characteristic appearance when stained with 5% acetic acid
  • If CIN II or III is present the transformation zone is excised with cutting diathermy. This is called a large loop excision of transformation zone’ or diathermy loop excision
  • Cervical screening reducing the cumulative incidence of cervical carcinoma by 91%

Malignant disease of the cervix

  • Incidence falling
  • Most common between ages of 45-55

Pathology

  • 90% of cervical malignancies are squamous cell carcinomas
  • 10% are adenocarcinomas from columnar epithelium with a poorer prognosis

Clinical features

  • Occult carcinoma is when there are no symptoms, diagnosis is made by biopsy
  • Clinical carcinoma may present with PCB, vaginal discharge and PMB. Pain is not an early feature.
  • In later stages involvement of the ureters, bladder, rectum and nerves causes uraemia, haematuria, rectal bleeding and pain

Spread and staging of malignant disease of the cervix

  • FIGO classification does not include lymph node involvement, so is therefore not s good indicator of survival
    • Stage 1 lesions confined to cervix
      • 1a(i) < 3mm in depth, <7mm across, 1a(ii)<5mm in depth, < 7mm across, Ib(i) tumour size <4cm, 1b(ii) tumour size >4cm
    • Stage 2  invasion into the vagina but not the pelvic side wall
      • 2a not in parametrium, 2b in paramterium
    • Stage 3 invasion of lower vagina or pelvic wall or causing ureteric obstruction
    • Stage 4 invasion of bladder or rectal mucosa or beyond true pelvis

Treatment for each stage

  • Stage 1a(i)  cone biopsy or simple hysterectomy
  • Stage 1a (ii)-2a radical hysterectomy +/- chemo-radiotherapy or chemo-radiotherapy alone of greater than 1b(ii).
  • Stage 2b and above  chemo-radiotherapy alone

Prognosis of malignant cervix

  • Depends on lymph node involvement, clinical stage and histological grade
  • Overall 65% 5 year survival rate
 

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>